Area of research
Biotechnology · Pulmonary and Respiratory Medicine
Research interest
Research focused on Canine Lymphoma and Organoid, with related work in Lymphoma, Doxorubicin, ATP-binding cassette transporter. Notable publications include 'Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy', 'Canine lymphoma: a review', and 'Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification'.
Tuft cells act as regenerative stem cells in the human intestine
Pre-existing subclones determine radioresistance in rectal cancer organoids
Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification
Feline Lymphoma: Patient Characteristics and Response Outcome of the COP-Protocol in Cats with Malignant Lymphoma in The Netherlands
Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy
Hyperthermia-triggered release of hypoxic cell radiosensitizers from temperature-sensitive liposomes improves radiotherapy efficacy <i>in vitro</i>
Triggered radiosensitizer delivery using thermosensitive liposomes and hyperthermia improves efficacy of radiotherapy: An in vitro proof of concept study
Canine lymphoma: a review
Mechanisms of Drug Resistance in Veterinary Oncology— A Review with an Emphasis on Canine Lymphoma
A longitudinal study of ABC transporter expression in canine multicentric lymphoma
Multi-drug resistance in a canine lymphoid cell line due to increased P-glycoprotein expression, a potential model for drug-resistant canine lymphoma
Masitinib reverses doxorubicin resistance in canine lymphoid cells by inhibiting the function of <scp>P</scp>‐glycoprotein
Prednisolone inclusion in a first-line multidrug cytostatic protocol for the treatment of canine lymphoma does not affect therapy results